Clinical Trials Logo

Clinical Trial Summary

Infantile colic is characterized by excessive crying (defined as crying that last at least 3 hours a day, for 3 days a week, for at least 3 weeks) in an otherwise healthy infant. The crying typically starts in the first few weeks of life and ends by 4-5 months of age. The condition is usually self-limited, with no long-term adverse effects; however, it may be very distressing to parents, hence, any safe and effective treatment would be desirable. Recently, it has been suggested that probiotics may offer some benefit.This is based on the results of one open randomized controlled trial. In this trial, 83 breast-fed infants with colic defined as >3 hours of crying on >3 days/week were randomly allocated to receive Lactobacillus reuteri DSM 17938 (108 colony-forming units, once daily 30 minutes after feeding) or simethicone (60 mg/day as 15 drops twice a day after feeding) for 28 days. Mothers followed a cow's milk free diet. By day 28 after randomization, mothers of infants in the probiotic group were significantly more likely than mothers of infants in the simethicone group to report a reduction from baseline in average crying time to less than 3 hours per day (95% vs. 7%). In addition, median crying times were significantly shorter in the probiotic group than in the simethicone group. No adverse effects of L. reuteri were reported.

Although the mechanism of action of L. reuteri for treating infantile colic has not been elucidated yet, the findings are very promising. However, there are some methodological limitations to the study, including no allocation concealment, no blinding, and no intention-to-treat analysis; these may result in selection, performance, and/or attrition biases and, eventually, invalidate the results. Another limitation of the study is the lack of a true placebo group. Given these consideration a new study is proposed that is aiming to overcome these limitations.


Clinical Trial Description

Eligible infants will be randomly assigned to receive either L. reuteri 108 CFU per day or placebo. Both the active treatment and placebo will be taken orally, 1 times daily, for 21 days.

All infants are eligible for screening. If a patient appears to meet the criteria for enrollment and express interest in the study, cow's milk elimination diet will be prescribed for 1 week to a breastfeeding mother (and to an infant, in case of formula fed infants). Care givers will be asked to record for 1 week symptoms of colic. Children fulfilling inclusion criteria will be asked to participate in the study. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01046617
Study type Interventional
Source Medical University of Warsaw
Contact
Status Completed
Phase Phase 3
Start date December 2009
Completion date April 2012

See also
  Status Clinical Trial Phase
Terminated NCT00954759 - The Effect of Chiropractic Treatment on Infantile Colic A Randomized, Controlled Trial N/A
Completed NCT01513304 - Chiropractic Manual Therapy in Infantile Colic N/A
Recruiting NCT02695784 - Probiotics After Discharge Phase 4
Completed NCT04374955 - The Effect of Probiotic Added to Maternal Diet on Infantile Colic and Intestinal Microbiota Content N/A
Terminated NCT03329222 - An Infant Formula Trial on Dietary Management of Infantile Colic N/A
Not yet recruiting NCT06462651 - Effect of Probiotic Limosilactobacillus Reuteri (L. Reuteri) on Crying and Fussing Time in Infants With Colic N/A
Withdrawn NCT01887444 - Lactobacillus Reuteri Supplementation in the Treatment of Infantile Colic N/A
Completed NCT04632888 - The Effect of Telephone Support for Breastfeeding Follow-up on Infantile Colic and Maternal Breastfeeding Self-efficacy N/A
Active, not recruiting NCT06299358 - Interventional Practices and Their Effectiveness in Infants With İnfantyl Colic N/A
Completed NCT02988791 - Evaluation of a Probiotic (Bifidobacterium in the Treatment of Infantile Colic (IC) N/A
Completed NCT02595515 - The Effect of Chiropractic Treatment of Infantile Colic N/A
Completed NCT01258153 - Preliminary Efficacy and Safety Study of Oral Nepadutant in Infant Colic Phase 2
Completed NCT03434249 - Clinical Trial to Evaluate the Efficacy of Bifidobacterium BB-12® in the Treatment of Infantile Colic N/A
Not yet recruiting NCT02430831 - Effect of Milk Formula Supplemented With L. Reuteri on Crying Time in Colicky Infants Less Than 3 Months Old Phase 4
Not yet recruiting NCT02094092 - Role of ProTectis on Infant Colic and Its Effect on Infant Crying Time and Maternal Mental Health N/A
Terminated NCT03477669 - Infantile Colic: Study of the Efficacy of Lactobacillus GG (ATCC 53103) Plus Chamomile in Breastfeeding Infants N/A
Completed NCT04262648 - Randomized Placebo-controlled Study of L. Reuteri NCIMB 30351 in GI Functional Disorders and Food Allergy in Newborns N/A
Completed NCT05244291 - Effect of Therapeutic Touch at Different Times on Infantile Colic According to Watson's Theory N/A
Not yet recruiting NCT06197100 - Supportive Care Training Given to Mothers of Babies With Infants Colic N/A
Terminated NCT02138656 - CHiropractic for Infantile Colic Study N/A